Helmut
★★★
avatar
Homepage
Vienna, Austria,
2004-08-26 16:29

Posting: # 8
Views: 11,206
 

 Generic Dimenhydrinate Injection USP for Motion Sickness [BE/BA News]

The FDA approved on 24 June 2004 a new generic of dimenhydrinate (dimenhydrinate injection USP, made by American Pharmaceutical Partners, Inc.), an antiemetic indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness. It is the generic equivalent of Dramamine (made by Pfizer) and will be available in 50 mg/mL, 1 mL vials.

Manufacturing of dimenhydrinate injection had been discontinued since 2000 for reasons other than safety or efficacy.

Medscape members may follow this link:
http://www.medscape.com/viewarticle/482387

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,514 posts in 4,141 threads, 1,336 registered users;
online 13 (0 registered, 13 guests [including 10 identified bots]).
Forum time (Europe/Vienna): 04:49 CEST

I have not failed 700 times. I have not failed once.
I have succeeded in proving
that those 700 ways will not work.    Thomas Alva Edison

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5